Patent 8377180 was granted and assigned to Teijin Pharma on February, 2013 by the United States Patent and Trademark Office.
The present invention provides an apparatus which stably provides highly concentrated oxygen to a patient, regardless of an environmental temperature and/or a highly concentrated oxygen gas flow rate. The present invention is an oxygen concentrator characterized in that an oxygen concentration sensor detecting a concentration of the oxygen gas produced by the oxygen concentrator, a temperature sensor measuring an environmental temperature and/or a flow rate sensor are provided, a control increasing/decreasing a supply airflow volume of the compressed air supply device based on a detected oxygen concentration detected value to maintain an oxygen concentration at a predetermined concentration is performed, and a control device is switched based on a value measured by the temperature sensor and/or flow rate sensor of the apparatus.